Radius Health Inc logo

RDUS - Radius Health Inc News Story

$10.95 0.0  0.4%

Last Trade - 25/09/20

Sector
Healthcare
Size
Mid Cap
Market Cap £399.3m
Enterprise Value £468.7m
Revenue £157.3m
Position in Universe 2886th / 6417

BRIEF-Menarini Group And Radius Health Announce Global License Agreement For The Development And Commercialization Of Elacestrant

Thu 23rd July, 2020 10:19pm
July 23 (Reuters) - Radius Health Inc  RDUS.O :
    * MENARINI GROUP AND RADIUS HEALTH ANNOUNCE GLOBAL LICENSE
AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALIZATION OF
ELACESTRANT
    * RADIUS HEALTH - WILL GET $30 MILLION AS UPFRONT PAYMENT &
UP TO
$320 MILLION IN ADDITIONAL MILESTONES ALONG WITH TIERED LOW TO
MID-TEEN PERCENTAGE ROYALTIES
    * RADIUS HEALTH INC - WILL CONTINUE TO BE RESPONSIBLE FOR
CONDUCT
AND COMPLETION OF PHASE 3 EMERALD STUDY THROUGH NDA FILING
    * RADIUS HEALTH INC - COSTS ASSOCIATED WITH PHASE 3 EMERALD
STUDY
THROUGH NDA FILING WILL BE REIMBURSED BY MENARINI GROUP

Source text for Eikon:  ID:nGNXbq4QjT 
Further company coverage:  RDUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.